Deep learning assesses heart allograft rejection from biopsy whole-slide images
A deep learning system analysing gigapixel endomyocardial biopsy slides detected allograft rejection with an AUC of 0.962, distinguished cellular and antibody-mediated rejection (AUCs 0.958 and 0.874) and graded rejection with an AUC of 0.833. In a human reader study it was non-inferior to conventional assessment and reduced interobserver variability and assessment time. Caveat: test cohorts from the US, Turkey and Switzerland are retrospective and the authors call for clinical trials.
Technology: Deep learning on whole-slide images for endomyocardial biopsies
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Rejection detection (AUC 0.962) was measured on a curated US dataset and independent test cohorts from Turkey and Switzerland, and a human reader study found the system non-inferior to conventional assessment.
- Still unknown: The authors state that clinical trials are needed to establish the efficacy of AI-assisted biopsy assessment.
- AI role: Deep learning system analysed gigapixel endomyocardial biopsy whole-slide images to detect, subtype and grade rejection.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41591-022-01709-2&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 105 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.